SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-023840
Filing Date
2024-03-01
Accepted
2024-03-01 16:05:35
Documents
2
Period of Report
2024-02-28

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3890
2 EX-24.1 alrn-ex24_1.htm EX-24.1 15544
  Complete submission text file 0000950170-24-023840.txt   20888
Mailing Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451
Business Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451 617-995-0900
AILERON THERAPEUTICS INC (Issuer) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AILERON THERAPEUTICS, INC. 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address
Ambros Reinhard J. (Reporting) CIK: 0001709690 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38130 | Film No.: 24709591